NOVEN PHARMACEUTICALS INC·4/A

Jan 25, 3:22 PM ET

MANTELLE JUAN A 4/A

4/A · NOVEN PHARMACEUTICALS INC · Filed Jan 25, 2005

Insider Transaction Report

Form 4/AAmended
Period: 2004-09-08
MANTELLE JUAN A
VP and Chief Technical Officer
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2004-09-081,849652 total
    Exercise: $8.67Exp: 2005-01-21Common Stock (1,849 underlying)
  • Exercise/Conversion

    Common Stock ($.0001 Par Value)

    2004-09-08$8.67/sh+1,849$16,0318,549 total
Footnotes (2)
  • [F1]10% exercisable after 1/21/1999; 20% exercisable after 1/21/2000; 20% exercisable after 1/21/2001; 25% exercisable after 1/21/2002; 25% exercisable after 1/21/2003. The reporting person has transferred 2,499 of such options to his ex-wife pursuant to a domestic relations order.
  • [F2]This amended Form 4 is filed to report the correct expiration date of the stock options in this line item. Other than this transaction, the remainder of the original report has not been restated in this amended Form 4.

Documents

1 file
  • 4
    doc4a.xml

    FORM 4/A SUBMISSION